Table 2.

Efficacy of treatment according to adherence

	High Adherence (n=48)	Moderate Adherence (n=14)	Low or Null Adherence (n=3)	Total (n=65)
PASI
T1	4.204 ± 1.409	4.643 ± 1.703	5.333 ± 0.764	4.351 ± 1.465
T 2	1.062 ± 1.278	1.643 ± 1.657	4.167 ± 1.041	1.331 ± 1.498
T3	0.542 ± 1.406	1.107 ± 1.655	6.666 ± 2.887	0.946 ± 1.983
T0-01	−3.142 (−3.541; 2.742)*	−3.000 (−4.080; 1.919)*	−1.167 (−2.601; 0.267)	−3.020 (−3.394; −2.646)*
T0-T2+^	−3.663(−4.147; 3.178)*	−3.536(−4.693; −2.378)*	1.333 (−4.536; 7.203)	−3.405 (−3.909; −2.900)*
BSA
T1	5.510 ± 1.773	6.000 ± 2.219	7.333 ± 1.155	5.700 ± 1.877
T2	1.573 ± 1.902	2.393 ± 2.543	5.833 ± 1.155	1.946 ± 2.206
T3	0.750 ± 1.910	1.857 ± 2.797	9.833 ± 4.537	1.408 ± 2.934
T0-01+	−3.938 (−4.505; −3.370)*	−3.607 (−4.967; −2.248)*	−1.500 (−1.500; −1.500)*	−3.754 (−4.261; −3.246)*
T0-T2+	−4.760 (−5.359; −4.161)*	−4.143 (−5.590; −2.695)*	2.500 (−8.112: 13.112)*	−4.293 (−4.962; −3.623)*
IGAm
T1	1.830 ± 0.808	2.070 ± 0.997	3.330 ± 0.577	1.950 ± 0.891
T2	0.750 ± 0.786	1.140 ± 1.167	3.000 ± 0.000	0.940 ± 0.982
T3	0.37 ± 0.815	0.790 ± 1.188	3.670 ± 0.577	0.620 ± 1.128
T0-01	−1.083 (−1.329; −0.838)*	−0.929 (−1.458; −0.399)*	−0.333 (−1.768; 1.101)*	−1.015 (−1.227; −0.803)*
T0-T2+	−1.458 (−1.719; −1.198)*	−1.286 (−1.859; −0.712)*	0.333 (−1.101; 1.768)*	−1.339 (−1.579: −1.097)*
PGA
T1	2.69 ±0.854	2.930 ± 0.917	4.000 ± 1.000	2.800 ± 0.905
T2	0.98 ± 1.021	1.430 ± 1.453	3.330 ± 0.577	1.180 ± 1.211
T3	0.46 ± 1051	0.930 ± 1.492	5.000 ± 1.000	0.770 ± 1.487
T0-01	−1.708 (−1.969; −1.447)*	−1.500 (−2.169; −0.830)*	−0.667 (−2.101; 0.768)*	−1.615 (−1.854; −1.377)*
T0-T2+^	−2.229(−2.512; −1.947)*	−2.000(−2.679; 1.321)*	1.000 (−1.484; 3.484)*	−2.031 (−2.331; −1.731)*

Data presented as mean ± standard deviation and mean difference (95% confidence interval)

^*Friedman test for repeated measure; p <0.001.

⁺Kruskal-Wallis test: + intergroup differences between high adherence and low adherence;

^{^}Intergroup differences moderate adherence vs low adherence; p <0.05.